Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Robert Gurny
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Devices
Occupations
Living Beings
Concepts & Ideas
Procedures
Objects
Sign-in to see full Profile
Network (preview)
26
Allémann, Eric
24
Doelker, Eric
18
Heller, Jorge
17
Tabatabay, Cyrus
16
Lange, Norbert
16
Delie, Florence
11
Behar-Cohen, Francine
11
Mayer, Joachim
11
Schwach-Abdellaoui, Khadija
10
Felt-Baeyens, Olivia
9
Einmahl, Suzanne
9
Besseghir, Kamel
8
Buri, P
8
Furrer, Pascal
8
Leroux, Jean-Christophe
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Robert Gurny (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Malaterre Vincent; Ogorka Joerg; Loggia Nicoletta; Gurny Robert
Oral osmotically driven systems: 30 years of development and clinical use.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2009;73(3):311-23.
-
2009: Patois Emilie; Osorio-da Cruz Suzanne; Tille Jean-Christophe; Walpoth Beat; Gurny Robert; Jordan Olivier
Novel thermosensitive chitosan hydrogels: in vivo evaluation.
Journal of biomedical materials research. Part A 2009;91(2):324-30.
-
2009: Cirstoiu-Hapca A; Buchegger F; Bossy L; Kosinski M; Gurny R; Delie F
Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2009;38(3):230-7.
-
2009: Innocente Francesco; Mandracchia Delia; Pektok Erman; Nottelet Benjamin; Tille Jean-Christophe; de Valence Sarra; Faggian Giuseppe; Mazzucco Alessandro; Kalangos Afksendiyos; Gurny Robert; Moeller Michael; Walpoth Beat H
Paclitaxel-eluting biodegradable synthetic vascular prostheses: a step towards reduction of neointima formation?
Circulation 2009;120(11 Suppl):S37-45.
-
2009: Vargas Angelica; Lange Norbert; Arvinte Tudor; Cerny Radovan; Gurny Robert; Delie Florence
Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activity.
Journal of drug targeting 2009;17(8):599-609.
-
2009: Zeisser-Labouèbe Magali; Mattiuzzo Marc; Lange Norbert; Gurny Robert; Delie Florence
Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancer.
Journal of drug targeting 2009;17(8):619-26.
-
2009: Gabriel Doris; Busso Nathalie; So Alexander; van den Bergh Hubert; Gurny Robert; Lange Norbert
Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritis.
Journal of controlled release : official journal of the Controlled Release Society 2009;138(3):225-34.
-
2009: Malaterre Vincent; Ogorka Joerg; Loggia Nicoletta; Gurny Robert
Approach to design push-pull osmotic pumps.
International journal of pharmaceutics 2009;376(1-2):56-62.
-
2009: Nottelet B; Pektok E; Mandracchia D; Tille J-C; Walpoth B; Gurny R; Möller M
Factorial design optimization and in vivo feasibility of poly(epsilon-caprolactone)-micro- and nanofiber-based small diameter vascular grafts.
Journal of biomedical materials research. Part A 2009;89(4):865-75.
-
2009: Malaterre Vincent; Ogorka Joerg; Loggia Nicoletta; Gurny Robert
Evaluation of the tablet core factors influencing the release kinetics and the loadability of push-pull osmotic systems.
Drug development and industrial pharmacy 2009;35(4):433-9.
-
2009: Gaumet Marie; Gurny Robert; Delie Florence
Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2009;36(4-5):465-73.
-
2009: Zeisser-Labouèbe Magali; Delie Florence; Gurny Robert; Lange Norbert
Screening of nanoparticulate delivery systems for the photodetection of cancer in a simple and cost-effective model.
Nanomedicine (London, England) 2009;4(2):135-43.
-
2009: Zeisser-Labouèbe Magali; Delie Florence; Gurny Robert; Lange Norbert
Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastases.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2009;71(2):207-13.
-
2009: Furrer Esther; Berdugo Marianne; Stella Cinzia; Behar-Cohen Francine; Gurny Robert; Feige Ulrich; Lichtlen Peter; Urech David M
Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
Investigative ophthalmology & visual science 2009;50(2):771-8.
-
2009: Malaterre Vincent; Metz Hendrik; Ogorka Joerg; Gurny Robert; Loggia Nicoletta; Mäder Karsten
Benchtop-magnetic resonance imaging (BT-MRI) characterization of push-pull osmotic controlled release systems.
Journal of controlled release : official journal of the Controlled Release Society 2009;133(1):31-6.
-
2008: Pektok Erman; Nottelet Benjamin; Tille Jean-Christophe; Gurny Robert; Kalangos Afksendiyos; Moeller Michael; Walpoth Beat H
Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation.
Circulation 2008;118(24):2563-70.
-
2008: Polak Marianne Berdugo; Valamanesh Fatemeh; Felt Olivia; Torriglia Alicia; Jeanny Jean-Claude; Bourges Jean-Louis; Rat Patrice; Thomas-Doyle Aoife; BenEzra David; Gurny Robert; Behar-Cohen Francine
Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucoma.
Investigative ophthalmology & visual science 2008;49(7):2993-3003.
-
2008: Collaud Sabine; Peng Qian; Gurny Robert; Lange Norbert
Thermosetting gel for the delivery of 5-aminolevulinic acid esters to the cervix.
Journal of pharmaceutical sciences 2008;97(7):2680-90.
-
2008: Vargas Angelica; Eid Michael; Fanchaouy Mohammed; Gurny Robert; Delie Florence
In vivo photodynamic activity of photosensitizer-loaded nanoparticles: formulation properties, administration parameters and biological issues involved in PDT outcome.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;69(1):43-53.
-
2008: Gaumet Marie; Vargas Angelica; Gurny Robert; Delie Florence
Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;69(1):1-9.
-
2008: Fotinos Nicolas; Convert Maruska; Piffaretti Jean-Claude; Gurny Robert; Lange Norbert
Effects on gram-negative and gram-positive bacteria mediated by 5-aminolevulinic Acid and 5-aminolevulinic acid derivatives.
Antimicrobial agents and chemotherapy 2008;52(4):1366-73.
-
2008: Eperon S; Bossy-Nobs L; Petropoulos I K; Gurny R; Guex-Crosier Y
A biodegradable drug delivery system for the treatment of postoperative inflammation.
International journal of pharmaceutics 2008;352(1-2):240-7.
-
2008: Capelle Martinus A H; Gurny Robert; Arvinte Tudor
High throughput methods to characterize protein permeation and release.
International journal of pharmaceutics 2008;350(1-2):272-8.
-
2008: Siepe Stefanie; Lueckel Barbara; Kramer Andrea; Ries Angelika; Gurny Robert
Assessment of tailor-made HPMC-based matrix minitablets comprising a weakly basic drug compound.
Drug development and industrial pharmacy 2008;34(1):46-52.
-
2008: Schuetz Yannic B; Gurny Robert; Jordan Olivier
A novel thermoresponsive hydrogel based on chitosan.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;68(1):19-25.
-
2007: Bourges J-L; Touchard E; Kowalczuk L; Berdugo M; Thomas-Doyle A; Bochot A; Gomez A; Azan F; Gurny R; Behar-Cohen F
[Drug delivery systems for intraocular applications]
Journal français d'ophtalmologie 2007;30(10):1070-88.
-
2007: Collaud S; Warloe T; Jordan O; Gurny R; Lange N
Clinical evaluation of bioadhesive hydrogels for topical delivery of hexylaminolevulinate to Barrett's esophagus.
Journal of controlled release : official journal of the Controlled Release Society 2007;123(3):203-10.
-
2007: Vargas Angelica; Zeisser-Labouèbe Magali; Lange Norbert; Gurny Robert; Delie Florence
The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems.
Advanced drug delivery reviews 2007;59(11):1162-76.
-
2007: Gaumet Marie; Gurny Robert; Delie Florence
Fluorescent biodegradable PLGA particles with narrow size distributions: preparation by means of selective centrifugation.
International journal of pharmaceutics 2007;342(1-2):222-30.
-
2007: Lallemand F; Varesio E; Felt-Baeyens O; Bossy Leila; Hopfgartner G; Gurny R
Biological conversion of a water-soluble prodrug of cyclosporine A.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2007;67(2):555-61.
-
2007: Campo Marino A; Gabriel Doris; Kucera Pavel; Gurny Robert; Lange Norbert
Polymeric photosensitizer prodrugs for photodynamic therapy.
Photochemistry and photobiology 2007;83(4):958-65.
-
2007: Gabriel Doris; Campo Marino A; Gurny Robert; Lange Norbert
Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes.
Bioconjugate chemistry 2007;18(4):1070-7.
-
2007: Zuluaga Maria-Fernanda; Mailhos Carolina; Robinson Gregory; Shima David T; Gurny Robert; Lange Norbert
Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration.
Investigative ophthalmology & visual science 2007;48(4):1767-72.
-
2007: Baer Ines; Gurny Robert; Margot Pierre
NIR analysis of cellulose and lactose--application to ecstasy tablet analysis.
Forensic science international 2007;167(2-3):234-41.
-
2007: Cirstoiu-Hapca A; Bossy-Nobs L; Buchegger F; Gurny R; Delie F
Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles.
International journal of pharmaceutics 2007;331(2):190-6.
-
2007: Capelle Martinus A H; Gurny Robert; Arvinte Tudor
High throughput screening of protein formulation stability: practical considerations.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2007;65(2):131-48.
-
2007: Demeule Barthélemy; Gurny Robert; Arvinte Tudor
Detection and characterization of protein aggregates by fluorescence microscopy.
International journal of pharmaceutics 2007;329(1-2):37-45.
-
2007: Demeule Barthélemy; Lawrence M Jayne; Drake Alex F; Gurny Robert; Arvinte Tudor
Characterization of protein aggregation: the case of a therapeutic immunoglobulin.
Biochimica et biophysica acta 2007;1774(1):146-53.
-
2007: Trimaille Thomas; Gurny Robert; Möller Michael
Poly(hexyl-substituted lactides): novel injectable hydrophobic drug delivery systems.
Journal of biomedical materials research. Part A 2007;80(1):55-65.
-
2006: Zeisser-Labouèbe Magali; Lange Norbert; Gurny Robert; Delie Florence
Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer.
International journal of pharmaceutics 2006;326(1-2):174-81.
-
2006: Bourges J L; Bloquel C; Thomas A; Froussart F; Bochot A; Azan F; Gurny R; BenEzra D; Behar-Cohen F
Intraocular implants for extended drug delivery: therapeutic applications.
Advanced drug delivery reviews 2006;58(11):1182-202.
-
2006: Felt-Baeyens O; Eperon S; Mora P; Limal D; Sagodira S; Breton P; Simonazzi B; Bossy-Nobs L; Guex-Crosier Y; Gurny R
Biodegradable scleral implants as new triamcinolone acetonide delivery systems.
International journal of pharmaceutics 2006;322(1-2):6-12.
-
2006: Costantino Luca; Gandolfi Francesca; Bossy-Nobs Leila; Tosi Giovanni; Gurny Robert; Rivasi Francesco; Vandelli Maria Angela; Forni Flavio
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures.
Biomaterials 2006;27(26):4635-45.
-
2006: Trimaille Thomas; Mondon Karine; Gurny Robert; Möller Michael
Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly(hexyl-substituted lactides).
International journal of pharmaceutics 2006;319(1-2):147-54.
-
2006: Fotinos Nicolas; Campo Marino A; Popowycz Florence; Gurny Robert; Lange Norbert
5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives.
Photochemistry and photobiology 2006;82(4):994-1015.
-
2006: Siepe Stefanie; Lueckel Barbara; Kramer Andrea; Ries Angelika; Gurny Robert
Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH.
International journal of pharmaceutics 2006;316(1-2):14-20.
-
2006: Siepe Stefanie; Herrmann Werner; Borchert Hans-Hubert; Lueckel Barbara; Kramer Andrea; Ries Angelika; Gurny Robert
Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: an EPR imaging study.
Journal of controlled release : official journal of the Controlled Release Society 2006;112(1):72-8.
-
2006: Demeule Barthélemy; Gurny Robert; Arvinte Tudor
Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregates.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2006;62(2):121-30.
-
2006: Nobs Leila; Buchegger Franz; Gurny Robert; Allémann Eric
Biodegradable nanoparticles for direct or two-step tumor immunotargeting.
Bioconjugate chemistry 2006;17(1):139-45.
-
2006: Bourges J L; Lallemand F; Agla E; Besseghir K; Dumont J M; BenEzra D; Gurny R; Behar-Cohen F
Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
Molecular vision 2006;12():1461-6.
-
2006: Nguyen Cung An; Konan-Kouakou Yvette Niamien; Allémann Eric; Doelker Eric; Quintanar-Guerrero David; Fessi Hatem; Gurny Robert
Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coating.
AAPS PharmSciTech 2006;7(3):63.
-
2006: Collaud S; Jichlinski P; Marti A; Aymon D; Gurny R; Lange N
An open pharmacokinetic study of hexylaminolevulinate-induced photodiagnosis after intravesical administration.
Drugs in R&D 2006;7(3):173-86.
-
2005: Lallemand Frederic; Perottet Philippe; Felt-Baeyens Olivia; Kloeti Werner; Philippoz Florence; Marfurt Judith; Besseghir Kamel; Gurny Robert
A water-soluble prodrug of cyclosporine A for ocular application: a stability study.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2005;26(1):124-9.
-
2005: Mora Paolo; Eperon Simone; Felt-Baeyens Olivia; Gurny Robert; Sagodira Serge; Breton Pascal; Guex-Crosier Yan
Trans-scleral diffusion of triamcinolone acetonide.
Current eye research 2005;30(5):355-61.
-
2005: Lallemand F; Furrer P; Felt-Baeyens O; Gex-Fabry M; Dumont J-M; Besseghir K; Gurny R
A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics.
International journal of pharmaceutics 2005;295(1-2):7-14.
-
2005: Konan-Kouakou Y N; Boch R; Gurny R; Allémann E
In vitro and in vivo activities of verteporfin-loaded nanoparticles.
Journal of controlled release : official journal of the Controlled Release Society 2005;103(1):83-91.
-
2005: Berger J; Reist M; Chenite A; Felt-Baeyens O; Mayer J M; Gurny R
Pseudo-thermosetting chitosan hydrogels for biomedical application.
International journal of pharmaceutics 2005;288(2):197-206.
-
2005: Berger J; Reist M; Chenite A; Felt-Baeyens O; Mayer J M; Gurny R
Pseudo-thermosetting chitosan hydrogels for biomedical application.
International journal of pharmaceutics 2005;288(1):17-25.
-
2005: Lallemand F; Felt-Baeyens O; Rudaz S; Hamel A R; Hubler F; Wenger R; Mutter M; Besseghir K; Gurny R
Conversion of cyclosporine A prodrugs in human tears vs rabbits tears.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2005;59(1):51-6.
-
2004: Vargas Angelica; Pegaz Bernadette; Debefve Elodie; Konan-Kouakou Yvette; Lange Norbert; Ballini Jean-Pierre; van den Bergh Hubert; Gurny Robert; Delie Florence
Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos.
International journal of pharmaceutics 2004;286(1-2):131-45.
-
2004: Nobs Leila; Buchegger Franz; Gurny Robert; Allémann Eric
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;58(3):483-90.
-
2004: Nobs Leila; Buchegger Franz; Gurny Robert; Allémann Eric
Current methods for attaching targeting ligands to liposomes and nanoparticles.
Journal of pharmaceutical sciences 2004;93(8):1980-92.
-
2004: Baydoun Luma; Furrer Pascal; Gurny Robert; Müller-Goymann Christel C
New surface-active polymers for ophthalmic formulations: evaluation of ocular tolerance.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;58(1):169-75.
-
2004: Schwach Grégoire; Oudry Nathalie; Giliberto Jean-Pierre; Broqua Pierre; Lück Martin; Lindner Hans; Gurny Robert
Biodegradable PLGA microparticles for sustained release of a new GnRH antagonist: part II. In vivo performance.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;57(3):441-6.
-
2004: Berger J; Reist M; Mayer J M; Felt O; Gurny R
Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;57(1):35-52.
-
2004: Berger J; Reist M; Mayer J M; Felt O; Peppas N A; Gurny R
Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;57(1):19-34.
-
2003: Schwach Grégoire; Oudry Nathalie; Delhomme Sophie; Lück Martin; Lindner Hans; Gurny Robert
Biodegradable microparticles for sustained release of a new GnRH antagonist--part I: Screening commercial PLGA and formulation technologies.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2003;56(3):327-36.
-
2003: Lallemand F; Felt-Baeyens O; Besseghir K; Behar-Cohen F; Gurny R
Cyclosporine A delivery to the eye: a pharmaceutical challenge.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2003;56(3):307-18.
-
2003: Nguyen Cung An; Allémann Eric; Schwach Grégoire; Doelker Eric; Gurny Robert
Synthesis of a novel fluorescent poly(D,L-lactide) end-capped with 1-pyrenebutanol used for the preparation of nanoparticles.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2003;20(2):217-22.
-
2003: Einmahl Suzanne; Ponsart Stéphanie; Bejjani Riad A; D'Hermies François; Savoldelli Michelle; Heller Jorge; Tabatabay Cyrus; Gurny Robert; Behar-Cohen Francine
Ocular biocompatibility of a poly(ortho ester) characterized by autocatalyzed degradation.
Journal of biomedical materials research. Part A 2003;67(1):44-53.
-
2003: Bourges Jean-Louis; Gautier Sandrine E; Delie Florence; Bejjani Riad A; Jeanny Jean-Claude; Gurny Robert; BenEzra David; Behar-Cohen Francine F
Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles.
Investigative ophthalmology & visual science 2003;44(8):3562-9.
-
2003: Konan Y N; Chevallier J; Gurny R; Allémann E
Encapsulation of p-THPP into nanoparticles: cellular uptake, subcellular localization and effect of serum on photodynamic activity.
Photochemistry and photobiology 2003;77(6):638-44.
-
2003: Konan Yvette Niamien; Berton Myriam; Gurny Robert; Allémann Eric
Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2003;18(3-4):241-9.
-
2003: Nguyen Cung An; Allémann Eric; Schwach Grégoire; Doelker Eric; Gurny Robert
Cell interaction studies of PLA-MePEG nanoparticles.
International journal of pharmaceutics 2003;254(1):69-72.
-
2003: Konan Yvette Niamien; Cerny Radovan; Favet Joselyne; Berton Myriam; Gurny Robert; Allémann Eric
Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2003;55(1):115-24.
-
2003: Nobs Leila; Buchegger Franz; Gurny Robert; Allémann Eric
Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods.
International journal of pharmaceutics 2003;250(2):327-37.
-
2002: Baeyens V; Felt-Baeyens O; Rougier S; Pheulpin S; Boisramé B; Gurny R
Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) for the treatment of external ocular infections in dogs.
Journal of controlled release : official journal of the Controlled Release Society 2002;85(1-3):163-8.
-
2002: Schwach-Abdellaoui Khadija; Moreau Marinette; Schneider Marc; Boisramc Bernard; Gurny Robert
Controlled delivery of metoclopramide using an injectable semi-solid poly(ortho ester) for veterinary application.
International journal of pharmaceutics 2002;248(1-2):31-7.
-
2002: Helle J; Barr J; Ng S Y; Shen H R; Schwach-Abdellaoui K; Gurny R; Vivien-Castioni N; Loup P J; Baehni P; Mombelli A
Development and applications of injectable poly(ortho esters) for pain control and periodontal treatment.
Biomaterials 2002;23(22):4397-404.
-
2002: Heller Jorge; Barr John; Ng Steven Y; Abdellauoi Khadija Schwach; Gurny Robert
Poly(ortho esters): synthesis, characterization, properties and uses.
Advanced drug delivery reviews 2002;54(7):1015-39.
-
2002: Einmahl Suzanne; Savoldelli Michelle; D'Hermies François; Tabatabay Cyrus; Gurny Robert; Behar-Cohen Francine
Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye.
Investigative ophthalmology & visual science 2002;43(5):1533-9.
-
2002: Furrer Pascal; Mayer Joachim M; Gurny Robert
Ocular tolerance of preservatives and alternatives.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2002;53(3):263-80.
-
2002: Konan Yvette Niamien; Gurny Robert; Allémann Eric
State of the art in the delivery of photosensitizers for photodynamic therapy.
Journal of photochemistry and photobiology. B, Biology 2002;66(2):89-106.
-
2002: Konan Yvette N; Gurny Robert; Allémann Eric
Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles.
International journal of pharmaceutics 2002;233(1-2):239-52.
-
2002: Heller Jorge; Barr John; Ng Steve; Shen Hui-Rong; Gurny Robert; Schwach-Abdelaoui Khadija; Rothen-Weinhold Alexandra; van de Weert Marco
Development of poly(ortho esters) and their application for bovine serum albumin and bupivacaine delivery.
Journal of controlled release : official journal of the Controlled Release Society 2002;78(1-3):133-41.
-
2002: Schwach-Abdellaoui K; Loup P J; Vivien-Castioni N; Mombelli A; Baehni P; Barr J; Heller J; Gurny R
Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: preliminary trial in humans.
AAPS pharmSci 2002;4(4):E20.
-
2002: Furrer Pascal; Mayer Joachim Michael; Plazonnet Bernard; Gurny Robert
Ocular tolerance of absorption enhancers in ophthalmic preparations.
AAPS pharmSci 2002;4(1):E2.
-
2001: Einmahl S; Capancioni S; Schwach-Abdellaoui K; Moeller M; Behar-Cohen F; Gurny R
Therapeutic applications of viscous and injectable poly(ortho esters).
Advanced drug delivery reviews 2001;53(1):45-73.
-
2001: Berton M; Turelli P; Trono D; Stein C A; Allémann E; Gurny R
Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles.
Pharmaceutical research 2001;18(8):1096-101.
-
2001: Schwach-Abdellaoui K; Monti A; Barr J; Heller J; Gurny R
Optimization of a novel bioerodible device based on auto-catalyzed poly(ortho esters) for controlled delivery of tetracycline to periodontal pocket.
Biomaterials 2001;22(12):1659-66.
-
2001: Delie F; Gurny R; Zimmer A
Fluorescence correlation spectroscopy for the characterisation of drug delivery systems.
Biological chemistry 2001;382(3):487-90.
-
2001: Rothen-Weinhold A; Schwach-Abdellaoui K; Barr J; Ng S Y; Shen H R; Gurny R; Heller J
Release of BSA from poly(ortho ester) extruded thin strands.
Journal of controlled release : official journal of the Controlled Release Society 2001;71(1):31-7.
-
2001: Einmahl S; Behar-Cohen F; D'Hermies F; Rudaz S; Tabatabay C; Renard G; Gurny R
A new poly(ortho ester)-based drug delivery system as an adjunct treatment in filtering surgery.
Investigative ophthalmology & visual science 2001;42(3):695-700.
-
2001: Delie F; Berton M; Allémann E; Gurny R
Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles.
International journal of pharmaceutics 2001;214(1-2):25-30.
-
2001: Furrer P; Berger J; Mayer J M; Gurny R
[A comparative study of the ocular tolerance of 3 timolol-based preparations: the influence of preservatives on ocular tolerance]
Journal français d'ophtalmologie 2001;24(1):13-9.
-
2001: Felt O; Baeyens V; Buri P; Gurny R
Delivery of antibiotics to the eye using a positively charged polysaccharide as vehicle.
AAPS pharmSci 2001;3(4):E34.
-
2001: De Jaeghere F; Allémann E; Cerny R; Galli B; Steulet A F; Müller I; Schütz H; Doelker E; Gurny R
pH-Dependent dissolving nano- and microparticles for improved peroral delivery of a highly lipophilic compound in dogs.
AAPS pharmSci 2001;3(1):E8.
-
2000: Furrer P; Plazonnet B; Mayer J M; Gurny R
Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants.
International journal of pharmaceutics 2000;207(1-2):89-98.
-
2000: Zignani M; Einmahl S; Baeyens V; Varesio E; Veuthey J L; Anderson J; Heller J; Tabatabay C; Gurny R
A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro release.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2000;50(2):251-5.
-
2000: Zignani M; Le Minh T; Einmahl S; Tabatabay C; Heller J; Anderson J M; Gurny R
Improved biocompatibility of a viscous bioerodible poly(ortho ester) by controlling the environmental pH during degradation.
Biomaterials 2000;21(17):1773-8.
-
2000: De Jaeghere F; Allémann E; Kubel F; Galli B; Cozens R; Doelker E; Gurny R
Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state.
Journal of controlled release : official journal of the Controlled Release Society 2000;68(2):291-8.
-
2000: Heller J; Barr J; Ng S Y; Shen H R; Schwach-Abdellaoui K; Einmahl S; Rothen-Weinhold A; Gurny R;
Poly(ortho esters) - their development and some recent applications.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2000;50(1):121-8.
-
2000: Schwach-Abdellaoui K; Vivien-Castioni N; Gurny R
Local delivery of antimicrobial agents for the treatment of periodontal diseases.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2000;50(1):83-99.
-
2000: Felt O; Carrel A; Baehni P; Buri P; Gurny R
Chitosan as tear substitute: a wetting agent endowed with antimicrobial efficacy.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2000;16(3):261-70.
-
2000: Einmahl S; Behar-Cohen F; Tabatabay C; Savoldelli M; D'Hermies F; Chauvaud D; Heller J; Gurny R
A viscous bioerodible poly(ortho ester) as a new biomaterial for intraocular application.
Journal of biomedical materials research 2000;50(4):566-73.
-
2000: Rothen-Weinhold A; Oudry N; Schwach-Abdellaoui K; Frutiger-Hughes S; Hughes G J; Jeannerat D; Burger U; Besseghir K; Gurny R
Formation of peptide impurities in polyester matrices during implant manufacturing.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2000;49(3):253-7.
-
2000: Vivien-Castioni N; Gurny R; Baehni P; Kaltsatos V
Salivary fluoride concentrations following applications of bioadhesive tablets and mouthrinses.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2000;49(1):27-33.
-
2000: De Jaeghere F; Allémann E; Feijen J; Kissel T; Doelker E; Gurny R
Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)-poly(ethylene oxide) (PLA-PEO) copolymer nanoparticles.
Pharmaceutical development and technology 2000;5(4):473-83.
-
2000: De Jaeghere F; Allemann E; Feijen J; Kissel T; Doelker E; Gurny R
Cellular uptake of PEO surface-modified nanoparticles: evaluation of nanoparticles made of PLA:PEO diblock and triblock copolymers.
Journal of drug targeting 2000;8(3):143-53.
-
1999: Berton M; Allémann E; Stein C A; Gurny R
Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 1999;9(2):163-70.
-
1999: Rothen-Weinhold A; Besseghir K; Vuaridel E; Sublet E; Oudry N; Kubel F; Gurny R
Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implants.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1999;48(2):113-21.
-
1999: Einmahl S; Zignani M; Varesio E; Heller J; Veuthey J L; Tabatabay C; Gurny R
Concomitant and controlled release of dexamethasone and 5-fluorouracil from poly(ortho ester).
International journal of pharmaceutics 1999;185(2):189-98.
-
1999: De Jaeghere F; Allémann E; Leroux J C; Stevels W; Feijen J; Doelker E; Gurny R
Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake.
Pharmaceutical research 1999;16(6):859-66.
-
1999: Felt O; Furrer P; Mayer J M; Plazonnet B; Buri P; Gurny R
Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention.
International journal of pharmaceutics 1999;180(2):185-93.
-
1999: Berton M; Benimetskaya L; Allémann E; Stein C A; Gurny R
Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localization.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1999;47(2):119-23.
-
1999: Furrer P; Mayer J M; Plazonnet B; Gurny R
Ocular tolerance of preservatives on the murine cornea.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1999;47(2):105-12.
-
1999: Rothen-Weinhold A; Besseghir K; Vuaridel E; Sublet E; Oudry N; Gurny R
Stability studies of a somatostatin analogue in biodegradable implants.
International journal of pharmaceutics 1999;178(2):213-21.
-
1999: Schwach-Abdellaoui K; Heller J; Gurny R
Synthesis and characterization of self-catalyzed poly(ortho-esters) based on decanediol and decanediol-lactate.
Journal of biomaterials science. Polymer edition 1999;10(3):375-89.
-
1998: Felt O; Buri P; Gurny R
Chitosan: a unique polysaccharide for drug delivery.
Drug development and industrial pharmacy 1998;24(11):979-93.
-
1998: Sintzel M B; Heller J; Ng S Y; Tabatabay C; Schwach-Abdellaoui K; Gurny R
In vitro drug release from self-catalyzed poly(ortho ester): case study of 5-fluorouracil.
Journal of controlled release : official journal of the Controlled Release Society 1998;55(2-3):213-8.
-
1998: Baeyens V; Kaltsatos V; Boisrame B; Fathi M; Gurny R
Evaluation of soluble Bioadhesive Ophthalmic Drug Inserts (BODI) for prolonged release of gentamicin: lachrymal pharmacokinetics and ocular tolerance.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 1998;14(3):263-72.
-
1998: Sintzel M B; Heller J; Ng S Y; Taylor M S; Tabatabay C; Gurny R
Synthesis and characterization of self-catalyzed poly(ortho ester).
Biomaterials 1998;19(7-9):791-800.
-
1998: Castioni N V; Baehni P C; Gurny R
Current status in oral fluoride pharmacokinetics and implications for the prophylaxis against dental caries.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1998;45(2):101-11.
-
1998: Baeyens V; Kaltsatos V; Boisramé B; Varesio E; Veuthey J L; Fathi M; Balant L P; Gex-Fabry M; Gurny R
Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infections.
Journal of controlled release : official journal of the Controlled Release Society 1998;52(1-2):215-20.
-
1998: Rothen-Weinhold A; Besseghir K; De Zelicourt Y; Gurny R
Development and evaluation in vivo of a long-term delivery system for vapreotide, a somatostatin analogue.
Journal of controlled release : official journal of the Controlled Release Society 1998;52(1-2):205-13.
-
1998: Zignani M; Bernatchez S F; Le Minh T; Tabatabay C; Anderson J M; Gurny R
Subconjunctival biocompatibility of a viscous bioerodable poly(ortho ester).
Journal of biomedical materials research 1998;39(2):277-85.
-
1998: Deshpande A A; Heller J; Gurny R
Bioerodible polymers for ocular drug delivery.
Critical reviews in therapeutic drug carrier systems 1998;15(4):381-420.
-
1997: Furrer P; Mayer J M; Gurny R
Confocal microscopy as a tool for the investigation of the anterior part of the eye.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 1997;13(6):559-78.
-
1997: Allémann E; Gravel P; Leroux J C; Balant L; Gurny R
Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement.
Journal of biomedical materials research 1997;37(2):229-34.
-
1997: Baeyens V; Gurny R
Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations.
Pharmaceutica acta Helvetiae 1997;72(4):191-202.
-
1997: Baeyens V; Varesio E; Veuthey J L; Gurny R
Determination of dexamethasone in tears by capillary electrophoresis.
Journal of chromatography. B, Biomedical sciences and applications 1997;692(1):222-6.
-
1996: Merkli A; Heller J; Tabatabay C; Gurny R
Purity and stability assessment of a semi-solid poly(ortho ester) used in drug delivery systems.
Biomaterials 1996;17(9):897-902.
-
1996: Leroux J C; Cozens R M; Roesel J L; Galli B; Doelker E; Gurny R
pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogs.
Pharmaceutical research 1996;13(3):485-7.
-
1996: Meseguer G; Buri P; Plazonnet B; Rozier A; Gurny R
Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 1996;12(4):481-8.
-
1996: Lee V H; Yamahara H; Gurny R; Sintzel M B; Martenet M; Gex-Fabry M; Balant L; Ohdo S; Podder S K
Basis for dosing time-dependent changes in the ocular and systemic absorption of topically applied timolol.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 1996;12(2):103-13.
-
1995: Leroux J C; Cozens R; Roesel J L; Galli B; Kubel F; Doelker E; Gurny R
Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice.
Journal of pharmaceutical sciences 1995;84(12):1387-91.
-
1995: Gurtler F; Kaltsatos V; Boisramé B; Deleforge J; Gex-Fabry M; Balant L P; Gurny R
Ocular availability of gentamicin in small animals after topical administration of a conventional eye drop solution and a novel long acting bioadhesive ophthalmic drug insert.
Pharmaceutical research 1995;12(11):1791-5.
-
1995: Allémann E; Brasseur N; Benrezzak O; Rousseau J; Kudrevich S V; Boyle R W; Leroux J C; Gurny R; Van Lier J E
PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours.
The Journal of pharmacy and pharmacology 1995;47(5):382-7.
-
1995: Leroux J C; De Jaeghere F; Anner B; Doelker E; Gurny R
An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes.
Life sciences 1995;57(7):695-703.
-
1995: Lescure F; Gurny R; Doelker E
In vitro and in vivo evaluation of progesterone implants based on new biodegradable poly(glutamic and glutamate esters) copolymers.
Journal of biomaterials science. Polymer edition 1995;6(9):797-807.
-
1994: Merkli A; Heller J; Tabatabay C; Gurny R
Gamma sterilization of a semi-solid poly(ortho ester) designed for controlled drug delivery--validation and radiation effects.
Pharmaceutical research 1994;11(10):1485-91.
-
1994: Bernatchez S F; Merkli A; Minh T L; Tabatabay C; Anderson J M; Gurny R
Biocompatibility of a new semisolid bioerodible poly(ortho ester) intended for the ocular delivery of 5-fluorouracil.
Journal of biomedical materials research 1994;28(9):1037-46.
-
1994: Leroux J C; Gravel P; Balant L; Volet B; Anner B M; Allémann E; Doelker E; Gurny R
Internalization of poly(D,L-lactic acid) nanoparticles by isolated human leukocytes and analysis of plasma proteins adsorbed onto the particles.
Journal of biomedical materials research 1994;28(4):471-81.
-
1994: Meseguer G; Gurny R; Buri P
In vivo evaluation of dosage forms: application of gamma scintigraphy to non-enteral routes of administration.
Journal of drug targeting 1994;2(4):269-88.
-
1993: Allémann E; Leroux J C; Gurny R; Doelker E
In vitro extended-release properties of drug-loaded poly(DL-lactic acid) nanoparticles produced by a salting-out procedure.
Pharmaceutical research 1993;10(12):1732-7.
-
1993: Bernatchez S F; Merkli A; Tabatabay C; Gurny R; Zhao Q H; Anderson J M; Heller J
Biotolerance of a semisolid hydrophobic biodegradable poly(ortho ester) for controlled drug delivery.
Journal of biomedical materials research 1993;27(5):677-81.
-
1993: Bernatchez S F; Tabatabay C; Gurny R
Sodium hyaluronate 0.25% used as a vehicle increases the bioavailability of topically administered gentamicin.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 1993;231(3):157-61.
-
1993: Merkli A; Heller J; Tabatabay C; Gurny R
Synthesis and characterization of a new biodegradable semi-solid poly(ortho ester) for drug delivery systems.
Journal of biomaterials science. Polymer edition 1993;4(5):505-16.
-
1992: Lescure F; Gurny R; Doelker E; Anderson J M
Long-term histopathological study of new polypeptidic biomaterials.
Biomaterials 1992;13(14):1009-11.
-
1990: Gurny R; Ryser J E; Tabatabay C; Martenet M; Edman P; Camber O
Precorneal residence time in humans of sodium hyaluronate as measured by gamma scintigraphy.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 1990;228(6):510-2.
-
1989: Lescure F; Gurny R; Doelker E; Pelaprat M L; Bichon D; Anderson J M
Acute histopathological response to a new biodegradable polypeptidic polymer for implantable drug delivery system.
Journal of biomedical materials research 1989;23(11):1299-313.
-
1989: Gander B; Gurny R; Doelker E; Peppas N A
Effect of polymeric network structure on drug release from cross-linked poly(vinyl alcohol) micromatrices.
Pharmaceutical research 1989;6(7):578-84.
-
1989: Lescure F; Gurny R; Doelker E; Augustynski J
[Use of principles of iontophoresis and electrophoresis for controlled release of medical substances]
Pharmaceutica acta Helvetiae 1989;64(8):210-9.
-
1988: Ibrahim H; Buri P; Gurny R
[Composition, structure and physiologic parameters of the lacrimal system; implications for the concept of ophthalmic forms]
Pharmaceutica acta Helvetiae 1988;63(6):146-54.
-
1987: Bindschaedler C; Gurny R; Doelker E
Osmotic water transport through cellulose acetate membranes produced from a latex system.
Journal of pharmaceutical sciences 1987;76(6):455-60.
-
1987: Camber O; Edman P; Gurny R
Influence of sodium hyaluronate on the meiotic effect of pilocarpine in rabbits.
Current eye research 1987;6(6):779-84.
-
1987: Bindschaedler C; Gurny R; Doelker E
Mechanically strong films produced from cellulose acetate latexes.
The Journal of pharmacy and pharmacology 1987;39(5):335-8.
-
1986: Gander B; Gurny R; Doelker E
[Matrices for controlled liberation by swelling of polymers. II: Preparation of drug delivery systems and analysis of liberation kinetics]
Pharmaceutica acta Helvetiae 1986;61(7):178-84.
-
1986: Gander B; Gurny R; Doelker E
[Matrices for controlled liberation of drugs from polymers. I. Mechanisms of the penetration of solvents into polymers]
Pharmaceutica acta Helvetiae 1986;61(5-6):130-4.
-
1984: Gurny R; Meyer J M; Peppas N A
Bioadhesive intraoral release systems: design, testing and analysis.
Biomaterials 1984;5(6):336-40.
-
1983: Korsmeyer R W; Gurny R; Doelker E; Buri P; Peppas N A
Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air.
Journal of pharmaceutical sciences 1983;72(10):1189-91.
-
1983: Peppas N A; Gurny R
[Relation between the structure of polymers and the controlled release of active ingredients]
Pharmaceutica acta Helvetiae 1983;58(1):2-8.
-
1982: Gurny R; Doelker E; Peppas N A
Modelling of sustained release of water-soluble drugs from porous, hydrophobic polymers.
Biomaterials 1982;3(1):27-32.
-
1982: Bindschaedler C; Gurny R
[Optimization of pharmaceutical formulations by the simplex method using a TI 59 calculator]
Pharmaceutica acta Helvetiae 1982;57(9):251-5.
Sign-in to see more
